Exane Derivatives’s Unilever NV New York Registry Shares UN Stock Holding History

Exane Derivatives’s Portfolio UN Stock Details UN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-44,134	Closed	-$2.57M	–	754
2019 Q1	$2.57M	Sell	44,134 -5,400	-11%	-$296K	0.51%	62
2018 Q4	$2.66M	Buy	49,534 +14,967	+43%	+$817K	0.48%	63
2018 Q3	$1.92M	Buy	34,567 +14,554	+73%	+$824K	0.36%	75
2018 Q2	$1.12M	Buy	20,013 +17,870	+834%	+$1,000K	0.19%	119
2018 Q1	$120K	Buy	+2,143	New	+$118K	0.02%	279

Other funds holding UN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

GRQ

Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

SCCM

Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Exane Derivatives's UN Position: Q2 2019 in Review

Exane Derivatives sold out of Unilever NV New York Registry Shares (UN) in Q2 2019, closing a stake of 44,134 shares — an estimated $2.57M sold.

Exane Derivatives first reported a position in UN in Q1 2018 and held it in 5 quarters. The position peaked at $2.66M in Q4 2018. 603 funds tracked by Wall St. Rank hold UN as of Q2 2019.

Exane Derivatives reported no remaining Unilever NV New York Registry Shares position as of Q2 2019 after selling out during the quarter.
Exane Derivatives sold 44,134 Unilever NV New York Registry Shares shares in Q2 2019, an estimated $2.57M.
Exane Derivatives first reported a position in Unilever NV New York Registry Shares in Q1 2018 and held it in 5 quarters.
Exane Derivatives's Unilever NV New York Registry Shares position peaked at $2.66M in Q4 2018.
603 funds tracked by Wall St. Rank held Unilever NV New York Registry Shares as of Q2 2019.

Based on Exane Derivatives's 13F filing for Q2 2019, filed 12 Jul 2019.